A glimpse of the pathogenetic mechanisms of Wnt/β-catenin signaling in diabetic nephropathy
- PMID: 24455745
- PMCID: PMC3886614
- DOI: 10.1155/2013/987064
A glimpse of the pathogenetic mechanisms of Wnt/β-catenin signaling in diabetic nephropathy
Abstract
The Wnt family of proteins belongs to a group of secreted lipid-modified glycoproteins with highly conserved cysteine residues. Prior results indicate that Wnt/β-catenin signaling plays a prominent role in cell differentiation, adhesion, survival, and apoptosis and is involved in organ development, tumorigenesis, and tissue fibrosis, among other functions. Accumulating evidence has suggested that Wnt/β-catenin exhibits a pivotal function in the progression of diabetic nephropathy (DN). In this review, we focused on discussing the dual role of Wnt/β-catenin in apoptosis and epithelial mesenchymal transition (EMT) formation of mesangial cells. Moreover, we also elucidated the effect of Wnt/β-catenin in podocyte dysfunction, tubular EMT formation, and renal fibrosis under DN conditions. In addition, the molecular mechanisms involved in this process are introduced. This information provides a novel molecular target of Wnt/β-catenin for the protection of kidney damage and in delay of the progression of DN.
Figures

Similar articles
-
Protective or deleterious role of Wnt/beta-catenin signaling in diabetic nephropathy: An unresolved issue.Pharmacol Res. 2019 Jun;144:151-157. doi: 10.1016/j.phrs.2019.03.022. Epub 2019 Mar 29. Pharmacol Res. 2019. PMID: 30935943 Review.
-
Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy.Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3959-3977. doi: 10.1007/s00210-023-02853-3. Epub 2023 Nov 22. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37991543 Free PMC article.
-
MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.Cell Death Dis. 2017 Mar 9;8(3):e2658. doi: 10.1038/cddis.2017.74. Cell Death Dis. 2017. PMID: 28277542 Free PMC article.
-
C-reactive protein exacerbates epithelial-mesenchymal transition through Wnt/β-catenin and ERK signaling in streptozocin-induced diabetic nephropathy.FASEB J. 2019 May;33(5):6551-6563. doi: 10.1096/fj.201801865RR. Epub 2019 Feb 22. FASEB J. 2019. PMID: 30794428
-
Glomerular mesangial cell and podocyte injuries in diabetic nephropathy.Nephrology (Carlton). 2018 Oct;23 Suppl 4:32-37. doi: 10.1111/nep.13451. Nephrology (Carlton). 2018. PMID: 30298646 Review.
Cited by
-
Pathomechanisms of Diabetic Kidney Disease.J Clin Med. 2023 Nov 27;12(23):7349. doi: 10.3390/jcm12237349. J Clin Med. 2023. PMID: 38068400 Free PMC article. Review.
-
The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach.Int J Mol Sci. 2022 Jan 12;23(2):807. doi: 10.3390/ijms23020807. Int J Mol Sci. 2022. PMID: 35054991 Free PMC article. Review.
-
Klotho attenuates diabetic nephropathy in db/db mice and ameliorates high glucose-induced injury of human renal glomerular endothelial cells.Cell Cycle. 2019 Mar-Apr;18(6-7):696-707. doi: 10.1080/15384101.2019.1580495. Epub 2019 Mar 17. Cell Cycle. 2019. PMID: 30784349 Free PMC article.
-
Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys.Br J Pharmacol. 2019 Jul;176(14):2642-2657. doi: 10.1111/bph.14687. Epub 2019 May 23. Br J Pharmacol. 2019. PMID: 30959575 Free PMC article.
-
Normoalbuminuric diabetic kidney disease.Front Med. 2017 Sep;11(3):310-318. doi: 10.1007/s11684-017-0542-7. Epub 2017 Jul 18. Front Med. 2017. PMID: 28721497 Review.
References
-
- Packham DK, Alves TP, Dwyer JP, et al. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database. The American Journal of Kidney Diseases. 2012;59(1):75–83. - PubMed
-
- Hovind P, Rossing P, Tarnow L, Smidt UM, Parving H-H. Progression of diabetic nephropathy. Kidney International. 2001;59(2):702–709. - PubMed
-
- Parving H-H, Harrington JT, Lewis J, et al. Diabetic nephropathy: prevention and treatment. Kidney International. 2001;60(5):2041–2055. - PubMed
-
- Sun YM, Su Y, Li J, Wang LF. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochemical and Biophysical Research Communications. 2013;433:359–361. - PubMed
-
- Kanwar YS, Wada J, Sun L, et al. Diabetic nephropathy: mechanisms of renal disease progression. Experimental Biology and Medicine. 2008;233(1):4–11. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical